Bank of America’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.9M | Sell |
2,055,985
-89,941
| -4% | -$1.7M | ﹤0.01% | 1954 |
|
|
2026
Q1 | $46.7M | Buy |
2,145,926
+451,336
| +27% | +$8.74M | ﹤0.01% | 1647 |
|
|
2025
Q4 | $36.5M | Buy |
1,694,590
+891,532
| +111% | +$18.8M | ﹤0.01% | 1780 |
|
|
2025
Q3 | $15.5M | Sell |
803,058
-113,737
| -12% | -$2.03M | ﹤0.01% | 2852 |
|
|
2025
Q2 | $15.7M | Buy |
916,795
+224,650
| +32% | +$9.58M | ﹤0.01% | 2804 |
|
|
2025
Q1 | $44.2M | Buy |
692,145
+82,526
| +14% | +$8.69M | ﹤0.01% | 1704 |
|
|
2024
Q4 | $74.1M | Sell |
609,619
-173,410
| -22% | -$21.3M | 0.01% | 1224 |
|
|
2024
Q3 | $97.8M | Buy |
783,029
+61,628
| +9% | +$8.52M | 0.01% | 1082 |
|
|
2024
Q2 | $114M | Buy |
721,401
+67,936
| +10% | +$8.73M | 0.01% | 945 |
|
|
2024
Q1 | $84.6M | Sell |
653,465
-558,912
| -46% | -$68.5M | 0.01% | 1117 |
|
|
2023
Q4 | $117M | Buy |
1,212,377
+684,531
| +130% | +$65.7M | 0.01% | 882 |
|
|
2023
Q3 | $64M | Buy |
527,846
+78,742
| +18% | +$8.9M | 0.01% | 1139 |
|
|
2023
Q2 | $51.4M | Sell |
449,104
-110,386
| -20% | -$14.2M | 0.01% | 1288 |
|
|
2023
Q1 | $77.1M | Buy |
559,490
+176,634
| +46% | +$22.9M | 0.01% | 1089 |
|
|
2022
Q4 | $49.6M | Sell |
382,856
-2,125
| -0.6% | -$246K | 0.01% | 1310 |
|
|
2022
Q3 | $42.6M | Buy |
384,981
+3,532
| +0.9% | +$356K | 0.01% | 1373 |
|
|
2022
Q2 | $28.6M | Sell |
381,449
-86,415
| -18% | -$6.36M | ﹤0.01% | 1710 |
|
|
2022
Q1 | $36.5M | Buy |
467,864
+72,336
| +18% | +$5.54M | ﹤0.01% | 1613 |
|
|
2021
Q4 | $35.6M | Sell |
395,528
-29,961
| -7% | -$2.56M | ﹤0.01% | 1672 |
|
|
2021
Q3 | $39.3M | Sell |
425,489
-36,614
| -8% | -$2.82M | ﹤0.01% | 1538 |
|
|
2021
Q2 | $35.9M | Sell |
462,103
-54,913
| -11% | -$4.16M | ﹤0.01% | 1609 |
|
|
2021
Q1 | $38.5M | Buy |
517,016
+131,696
| +34% | +$12.2M | ﹤0.01% | 1492 |
|
|
2020
Q4 | $65.7M | Sell |
385,320
-65,648
| -15% | -$9.73M | 0.01% | 1006 |
|
|
2020
Q3 | $63.3M | Buy |
450,968
+20,946
| +5% | +$3.18M | 0.01% | 956 |
|
|
2020
Q2 | $69M | Sell |
430,022
-37,190
| -8% | -$5.06M | 0.01% | 875 |
|
|
2020
Q1 | $45.7M | Buy |
467,212
+50,455
| +12% | +$5.77M | 0.01% | 1005 |
|
|
2019
Q4 | $53.8M | Buy |
416,757
+24,824
| +6% | +$2.51M | 0.01% | 1130 |
|
|
2019
Q3 | $29.5M | Sell |
391,933
-245,598
| -39% | -$29M | ﹤0.01% | 1498 |
|
|
2019
Q2 | $96.9M | Buy |
637,531
+205,510
| +48% | +$25M | 0.01% | 749 |
|
|
2019
Q1 | $51.5M | Sell |
432,021
-28,570
| -6% | -$3.67M | 0.01% | 1088 |
|
|
2018
Q4 | $50.3M | Buy |
460,591
+382,953
| +493% | +$47.9M | 0.01% | 993 |
|
|
2018
Q3 | $12.5M | Sell |
77,638
-240,829
| -76% | -$32.9M | ﹤0.01% | 2255 |
|
|
2018
Q2 | $42.1M | Buy |
318,467
+216,622
| +213% | +$20.4M | 0.01% | 1211 |
|
|
2018
Q1 | $7.55M | Buy |
101,845
+20,417
| +25% | +$1.36M | ﹤0.01% | 2687 |
|
|
2017
Q4 | $4.53M | Sell |
81,428
-52,000
| -39% | -$2.75M | ﹤0.01% | 3215 |
|
|
2017
Q3 | $6.05M | Buy |
133,428
+79,508
| +147% | +$3.18M | ﹤0.01% | 2996 |
|
|
2017
Q2 | $1.82M | Sell |
53,920
-10,351
| -16% | -$337K | ﹤0.01% | 3968 |
|
|
2017
Q1 | $1.9M | Buy |
64,271
+922
| +1% | +$28.5K | ﹤0.01% | 3913 |
|
|
2016
Q4 | $1.74M | Buy |
63,349
+9,868
| +18% | +$396K | ﹤0.01% | 3885 |
|
|
2016
Q3 | $3.28M | Buy |
53,481
+15,610
| +41% | +$472K | ﹤0.01% | 3214 |
|
|
2016
Q2 | $723K | Sell |
37,871
-1,124
| -3% | -$20.8K | ﹤0.01% | 4413 |
|
|
2016
Q1 | $761K | Buy |
38,995
+372
| +1% | +$6.5K | ﹤0.01% | 4297 |
|
|
2015
Q4 | $1.49M | Buy |
38,623
+21,849
| +130% | +$708K | ﹤0.01% | 4048 |
|
|
2015
Q3 | $538K | Sell |
16,774
-25,096
| -60% | -$852K | ﹤0.01% | 4755 |
|
|
2015
Q2 | $1.27M | Buy |
41,870
+6,423
| +18% | +$131K | ﹤0.01% | 3894 |
|
|
2015
Q1 | $471K | Sell |
35,447
-404,343
| -92% | -$5.39M | ﹤0.01% | 4355 |
|
|
2014
Q4 | $6.36M | Sell |
439,790
-46,426
| -10% | -$786K | ﹤0.01% | 2341 |
|
|
2014
Q3 | $10.3M | Buy |
486,216
+65,154
| +15% | +$1.47M | ﹤0.01% | 1923 |
|
|
2014
Q2 | $12.5M | Buy |
421,062
+124,133
| +42% | +$3.92M | ﹤0.01% | 1742 |
|
|
2014
Q1 | $7.13M | Sell |
296,929
-1,722
| -0.6% | -$43.9K | ﹤0.01% | 2069 |
|
|
2013
Q4 | $6.08M | Buy |
298,651
+13,161
| +5% | +$391K | ﹤0.01% | 2303 |
|
|
2013
Q3 | $13.5M | Buy |
285,490
+206,275
| +260% | +$7.94M | 0.01% | 1537 |
|
|
2013
Q2 | $3.01M | Buy |
+79,215
| New | +$2.83M | ﹤0.01% | 2766 |
|
Other funds holding SRPT
EAM
Bank of America's SRPT Position: Q2 2026 in Review
Bank of America reduced its Sarepta Therapeutics (SRPT) stake by 4.2% in Q2 2026, selling an estimated $1.7M and leaving 2,055,985 shares worth $36.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1954.
Bank of America first reported a position in SRPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $117M in Q4 2023. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Bank of America held 2,055,985 shares of Sarepta Therapeutics worth $36.9M as of Q2 2026.
- Bank of America sold 89,941 Sarepta Therapeutics shares in Q2 2026, an estimated $1.7M.
- Sarepta Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #1954 holding.
- Bank of America first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Bank of America's Sarepta Therapeutics position peaked at $117M in Q4 2023.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.